These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 19458681

  • 1. Alzheimer's theory makes a splash.
    Schnabel J.
    Nature; 2009 May 21; 459(7245):310. PubMed ID: 19458681
    [No Abstract] [Full Text] [Related]

  • 2. Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease.
    DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM.
    Proc Natl Acad Sci U S A; 2001 Jul 17; 98(15):8850-5. PubMed ID: 11438712
    [Abstract] [Full Text] [Related]

  • 3. Imaging Alzheimer's amyloid.
    Selkoe DJ.
    Nat Biotechnol; 2000 Aug 17; 18(8):823-4. PubMed ID: 10932146
    [No Abstract] [Full Text] [Related]

  • 4. Alzheimer's disease-type brain abnormalities in animal models.
    Price DL, Martin LJ, Sisodia SS, Walker LC, Cork LC.
    Prog Clin Biol Res; 1992 Aug 17; 379():271-87. PubMed ID: 1409750
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Isomerization of the Asp7 residue results in zinc-induced oligomerization of Alzheimer's disease amyloid beta(1-16) peptide.
    Tsvetkov PO, Popov IA, Nikolaev EN, Archakov AI, Makarov AA, Kozin SA.
    Chembiochem; 2008 Jul 02; 9(10):1564-7. PubMed ID: 18506864
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Abeta(25-35) as proxyholder for amyloidogenic peptides: in vivo evidence.
    Gulyaeva NV, Stepanichev MY.
    Exp Neurol; 2010 Mar 02; 222(1):6-9. PubMed ID: 20043907
    [No Abstract] [Full Text] [Related]

  • 14. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
    Schmidt AM, Sahagan B, Nelson RB, Selmer J, Rothlein R, Bell JM.
    Curr Opin Investig Drugs; 2009 Jul 02; 10(7):672-80. PubMed ID: 19579173
    [Abstract] [Full Text] [Related]

  • 15. Amyloid hypothesis of Alzheimer's rides high--for now.
    Schehr RS.
    Nat Biotechnol; 1997 Jan 02; 15(1):19-20. PubMed ID: 9035100
    [No Abstract] [Full Text] [Related]

  • 16. Plasmin deficiency does not alter endogenous murine amyloid beta levels in mice.
    Tucker HM, Simpson J, Kihiko-Ehmann M, Younkin LH, McGillis JP, Younkin SG, Degen JL, Estus S.
    Neurosci Lett; 2004 Sep 30; 368(3):285-9. PubMed ID: 15364412
    [Abstract] [Full Text] [Related]

  • 17. Gangliosides determine the amyloid pathology of Alzheimer's disease.
    Oikawa N, Yamaguchi H, Ogino K, Taki T, Yuyama K, Yamamoto N, Shin RW, Furukawa K, Yanagisawa K.
    Neuroreport; 2009 Aug 05; 20(12):1043-6. PubMed ID: 19590389
    [Abstract] [Full Text] [Related]

  • 18. Elevation of plasma beta-amyloid level by glucose loading in Alzheimer mouse models.
    Takeda S, Sato N, Uchio-Yamada K, Sawada K, Kunieda T, Takeuchi D, Kurinami H, Shinohara M, Rakugi H, Morishita R.
    Biochem Biophys Res Commun; 2009 Jul 24; 385(2):193-7. PubMed ID: 19450564
    [Abstract] [Full Text] [Related]

  • 19. The emerging role of cystatins in Alzheimer's disease.
    Zerovnik E.
    Bioessays; 2009 Jun 24; 31(6):597-9. PubMed ID: 19382231
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.